Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies

2016 ◽  
Vol 36 (10) ◽  
pp. 1055-1064 ◽  
Author(s):  
David F. Blackburn ◽  
Charity D. Evans ◽  
Dean T. Eurich ◽  
Kerry D. Mansell ◽  
Derek J. Jorgenson ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cardiovascular Health ◽  
Controlled Trial ◽  
Community Pharmacists ◽  
Cluster Randomized Controlled Trial ◽  
Community Pharmacies ◽  
Randomized Controlled ◽  
Trial Testing ◽  
Cluster Randomized

Evaluation of a collaborative protocolized approach by community pharmacies and general medical practitioners for an Australian minor ailments scheme: study protocol for a cluster-randomized controlled trial (Preprint)

2019 ◽  
Author(s):  
Sarah Dineen-Griffin ◽  
Victoria Garcia Cardenas ◽  
Kylie Williams ◽  
Shalom Isaac Benrimoj
Keyword(s):  
Randomized Controlled Trial ◽  
Usual Care ◽  
Controlled Trial ◽  
Self Care ◽  
Cluster Randomized Controlled Trial ◽  
Control Group ◽  
Community Pharmacies ◽  
Randomized Controlled ◽  
Minor Ailments ◽  
Cluster Randomized

BACKGROUND Internationally, governments have been investing in supporting pharmacists to take on an expanded role to support self-care for health system efficiency. There is consistent evidence that minor ailment schemes (MAS) promote efficiencies within the healthcare system. The cost savings and health outcomes demonstrated in the UK and Canada opens up new opportunities for pharmacists to effect sustainable changes through MAS delivery in Australia. OBJECTIVE This trial is evaluating the clinical, economic and humanistic impact of an Australian minor ailments service (AMAS), compared with usual pharmacy care in a cluster-randomized controlled trial in Western Sydney, Australia. METHODS The cluster-randomized controlled trial design has an intervention and a control group, comparing individuals receiving a structured intervention with those receiving usual care for specific common ailments. Participants will be community pharmacies, general practices and patients located in Western Sydney Primary Health Network region. 30 community pharmacies will be randomly assigned to either intervention or control group. Each will recruit 24 patients seeking, aged 18 years or older, presenting to the pharmacy in person with a symptom-based or product-based request for one of the following ailments (reflux, cough, common cold, headache (tension or migraine), primary dysmenorrhoea and low back pain). Intervention pharmacists will deliver protocolized care to patients using clinical treatment pathways with agreed referral points and collaborative systems boosting clinician-pharmacist communication. Patients recruited in control pharmacies will receive usual care. The co-primary outcomes are rates of appropriate use of nonprescription medicines and rates of appropriate medical referral. Secondary outcomes include self-reported symptom resolution, time to resolution of symptoms, health services resource utilization and EQ VAS. Differences in the primary outcomes between groups will be analyzed at the individual patient level accounting for correlation within clusters with generalized estimating equations. The economic impact of the model will be evaluated by cost analysis compared with usual care. RESULTS The study began in July 2018. At the time of submission, 30 community pharmacies have been recruited. Pharmacists from the 15 intervention pharmacies have been trained. 27 general practices have consented. Pharmacy patient recruitment began in August 2018 and is ongoing and monthly targets are being met. Recruitment will be completed March 31st, 2019. CONCLUSIONS This study may demonstrate the utilization and efficacy of a protocolized intervention to manage minor ailments in the community, and will assess the clinical, economic and humanistic impact of this intervention in Australian pharmacy practice. Pharmacists supporting patient self-care and self-medication may contribute greater efficiency of healthcare resources and integration of self-care in the health system. The proposed model and developed educational content may form the basis of a MAS national service, with protocolized care for common ailments using a robust framework for management and referral. CLINICALTRIAL Registered with Australian New Zealand Clinical Trials Registry (ANZCTR) and allocated the ACTRN: ACTRN12618000286246. Registered on 23 February 2018.

scholarly journals Creating a synergy effect: A cluster randomized controlled trial testing the effect of a tailored multimedia intervention on patient outcomes

2018 ◽  
Vol 101 (8) ◽  
pp. 1419-1426 ◽  
Author(s):  
Annemiek J. Linn ◽  
Liset van Dijk ◽  
Julia C.M. van Weert ◽  
Beniam G. Gebeyehu ◽  
Ad. A. van Bodegraven ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Patient Outcomes ◽  
Controlled Trial ◽  
Cluster Randomized Controlled Trial ◽  
Synergy Effect ◽  
Randomized Controlled ◽  
Trial Testing ◽  
Cluster Randomized ◽  
Multimedia Intervention

scholarly journals Expression of Concern to: A protocol for a cluster-randomized controlled trial testing an empowerment intervention to prevent sexual assault in upper primary school adolescents in the informal settlements of Nairobi, Kenya

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Clea Sarnquist ◽  
Jennifer Lee Kang ◽  
Mary Amuyunzu-Nyamongo ◽  
Gabriel Oguda ◽  
Dorothy Otieno ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Sexual Assault ◽  
Primary School ◽  
Controlled Trial ◽  
Informal Settlements ◽  
Cluster Randomized Controlled Trial ◽  
Randomized Controlled ◽  
Trial Testing ◽  
Cluster Randomized

An amendment to this paper has been published and can be accessed via the original article.

Sign in / Sign up

Export Citation Format

Share Document